Instant Cohort Access. Zero-Lag Tissue Sourcing.
Searchable, phenotyped clinical tissue engine delivering cohort-level insights in weeks, eliminating multi-year tissue procurement delays.
Powered by actual tissue. Confirmed in the lab.
A structured resource of more than 200,000 real skin samples enables pharma teams to quantitatively study regional, clinical, and biological variation.

Searchable, phenotyped clinical tissue engine delivering cohort-level insights in weeks, eliminating multi-year tissue procurement delays.
Mines cellular heterogeneity across body regions, disease phenotypes, and aging states to discover novel & specific therapeutic targets using spatial transcriptomics.
Find the right drug for the right patient by validating target expression and biomarker prevalence across hundreds of thousands of real human disease samples prior to advancing assets.
On-demand sectioning of preserved tissue blocks allows repeated spatial assays on identical tissue architectures over time, building a multi-layered digital spatial library.
A platform dedicated to skin science.
Accelerate your CPG development pipeline 5x faster with SkinSync™. Our lab-in-the-loop platform integrates human tissue biology, active design, formulation, and topical barrier delivery into one continuously improving research ecosystem.
Novel peptide concepts informed by regional and age-associated differences in human skin biology.
Active systems designed to address oxidative stress with stronger biological relevance and formulation compatibility.
Mechanism-led approaches to hyperpigmentation grounded in tissue-scale biological insight.
Permeation and bioavailability strategies derived from a proprietary database of standardized skin delivery experiments.
01
Generates novel, patentable peptides and bio-actives in weeks, slashing ingredient R&D cycles by 5x for targeted consumer claims.
02
Optimizes the pairing of novel and existing active ingredients with the best solvents for tolerability and skin delivery, greatly reducing development costs upfront.
03
Leverages 7,000+ bioavailability studies to ensure active ingredients reliably cross the stratum corneum barrier to reach cellular target receptors.
04
Cross-applies human biobank tissue insights to give consumer skincare products pharmaceutical-grade mechanism-of-action data for marketing claims.